Facioscapulohumeral Muscular Dystrophy is a genetic muscle disorder which mostly affects the muscles of the face, the upper arms and shoulders. The disease starts showing prominence after the age of 20 when weakness of the affected muscles becomes rather significant. Facial weakness may start in childhood but it is only in the early 20s that the symptoms become prominent.
HOW IS FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY DIAGNOSED?
Genetic testing is the most common diagnostic method for Facioscapulohumeral Muscular Dystrophy. Rheumatologists may order additional tests for determining nerve conduction velocity for confirming diagnosis. Another common test is muscle biopsy for evaluating the muscle status through biochemical tests
HOW IS FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY TREATED?
The treatment of FSHD is directed toward the specific symptoms that are apparent in each individual. Such treatment may require the coordinated efforts of a team of medical professionals, such as physicians who specialize in the treatment of neurological disorders (neurologists), physicians who diagnose and treat disorders of the skeleton, joints, muscles, and related tissues (orthopedists), physicians who specialize in physical medicine and rehabilitation (physiatrists), specialists who assess and treat hearing problems (audiologists), and/or other healthcare professionals.
DID YOU KNOW?
Around 2,000-2,500 people in the UK have FSH. Several generations of a family are often affected by the condition. It can be diagnosed at any age and can vary widely between individuals, even within the same family. One-third of those with the condition are unaware of the symptoms right into old age.